Free tool
Cell therapy stocks
We cover 6 companies grouped under the Cell therapy theme. The median market value in the group is $419.91M. Across the group, the median move over the past trading day is +2.13%. Price change over the past year runs from −60.4% to +418.8% across the middle 80 percent of the group, with a median of +10.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.11% |
| IMMX | Immix Biopharma, Inc. | $968.90M | Small cap | +589.05% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $501.00M | Small cap | +248.46% |
| 219A.T | HEARTSEED INC | $338.82M | Small cap | −32.33% |
| 4584.T | Kidswell Bio Corporation | $55.83M | Micro cap | −24.37% |
| FBLG | FibroBiologics, Inc. | $9.32M | Micro cap | −88.54% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.